MODULATION OF EIF4E EXPRESSION

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130178513A1
SERIAL NO

13780955

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Oligomeric compounds, compositions and methods are provided for modulating the expression of eIF4E. The antisense compounds may be single- or double-stranded and are targeted to nucleic acid encoding eIF4E. Methods of using these compounds for modulation of eIF4E expression and for diagnosis and treatment of diseases and conditions associated with expression of eIF4E are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ISIS PHARMACEUTICALS INCCALIFORNIA USA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bhat, Balkrishin Carlsbad, US 2 121
Dobie, Kenneth W Del Mar, US 319 3223
Graff, Jeremy Richard Indianapolis, US 9 141
Marcusson, Eric G San Francisco, US 63 1332
Swayze, Eric E Encinitas, US 355 10308

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation